Advertisement
CERS vs PLSE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a StrongBuy and PLSE is a Hold.
CERS's RSI Indicator ascends from oversold territory
The RSI Indicator for CERS moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In 23 of the 28 cases the stock moved higher. This puts the odds of a move higher at 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on CERS as a result. In 84 of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for CERS just turned positive on October 20, 2026. Looking at past instances where CERS's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.
Following a +7.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where CERS advanced for three days, in 170 of 226 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CERS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
CERS broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CERS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.648) is normal, around the industry mean (2.874). P/E Ratio (-77.000) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (2.219) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. CERS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CERS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
PLSE's Indicator enters downward trend
The Aroon Indicator for PLSE entered a downward trend on October 22, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 206 similar instances where the Aroon Indicator formed such a pattern. In 181 of the 206 cases the stock moved lower. This puts the odds of a downward move at 88%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for PLSE crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLSE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on PLSE as a result. In 77 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
The Moving Average Convergence Divergence (MACD) for PLSE just turned positive on October 22, 2026. Looking at past instances where PLSE's MACD turned positive, the stock continued to rise in 51 of 56 cases over the following month. The odds of a continued upward trend are 90%.
PLSE moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where PLSE advanced for three days, in 227 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
PLSE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. PLSE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PLSE's P/B Ratio (37.762) is very high in comparison to the industry average of (4.961). P/E Ratio (-45.026) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. PLSE's P/S Ratio (2500.000) is very high in comparison to the industry average of (56.876).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CERS | PLSE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 20 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | 83 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 37 | |
SMR RATING 1..100 | 94 | 98 | |
PRICE GROWTH RATING 1..100 | 49 | 34 | |
P/E GROWTH RATING 1..100 | 17 | 96 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CERS's Valuation (8) in the Medical Specialties industry is significantly better than the same rating for PLSE (83). This means that CERS’s stock grew significantly faster than PLSE’s over the last 12 months.
PLSE's Profit vs Risk Rating (37) in the Medical Specialties industry is somewhat better than the same rating for CERS (100). This means that PLSE’s stock grew somewhat faster than CERS’s over the last 12 months.
CERS's SMR Rating (94) in the Medical Specialties industry is in the same range as PLSE (98). This means that CERS’s stock grew similarly to PLSE’s over the last 12 months.
PLSE's Price Growth Rating (34) in the Medical Specialties industry is in the same range as CERS (49). This means that PLSE’s stock grew similarly to CERS’s over the last 12 months.
CERS's P/E Growth Rating (17) in the Medical Specialties industry is significantly better than the same rating for PLSE (96). This means that CERS’s stock grew significantly faster than PLSE’s over the last 12 months.
| CERS | PLSE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | N/A |
| Stochastic ODDS (%) | 1 day ago 85% | 1 day ago 78% |
| Momentum ODDS (%) | 1 day ago 82% | 1 day ago 87% |
| MACD ODDS (%) | 1 day ago 80% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 78% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 83% |
| Advances ODDS (%) | 2 days ago 75% | 1 day ago 88% |
| Declines ODDS (%) | 15 days ago 83% | 7 days ago 85% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 85% | 1 day ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CERS’s FA Score shows that 2 FA rating(s) are green while PLSE’s FA Score has 0 green FA rating(s).
- CERS’s FA Score: 2 green, 3 red.
- PLSE’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CERS’s TA Score shows that 4 TA indicator(s) are bullish while PLSE’s TA Score has 5 bullish TA indicator(s).
- CERS’s TA Score: 4 bullish, 4 bearish.
- PLSE’s TA Score: 5 bullish, 3 bearish.
Price Growth
CERS (@Medical/Nursing Services) experienced а +6.70% price change this week, while PLSE (@Pharmaceuticals: Other) price change was +10.77% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.
Reported Earning Dates
CERS is expected to report earnings on Nov 02, 2026.
PLSE is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+0.74% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
CERS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CERS has been loosely correlated with ICUI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then ICUI could also see price increases.
| Ticker / NAME | Correlation To CERS | 1D Price Change % | ||
|---|---|---|---|---|
| CERS | 100% | -3.35% | ||
| ICUI - CERS | 46% Loosely correlated | +4.66% | ||
| UTMD - CERS | 45% Loosely correlated | +0.46% | ||
| RVTY - CERS | 44% Loosely correlated | +0.48% | ||
| ATRC - CERS | 43% Loosely correlated | +2.83% | ||
| DHR - CERS | 43% Loosely correlated | -1.76% | ||
More | ||||
PLSE and
Correlation & Price change
A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with NVST. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To PLSE | 1D Price Change % | ||
|---|---|---|---|---|
| PLSE | 100% | +2.67% | ||
| NVST - PLSE | 39% Loosely correlated | +3.36% | ||
| CERS - PLSE | 38% Loosely correlated | -3.35% | ||
| CLPT - PLSE | 32% Poorly correlated | N/A | ||
| ARAY - PLSE | 32% Poorly correlated | -2.19% | ||
| TMCI - PLSE | 32% Poorly correlated | +3.38% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FBDC | 16.33 | 0.31 | +1.96% |
| FT Confluence BDC & Specialty Finance Income ETF (FBDC) | |||
| GNMA | 42.57 | 0.30 | +0.70% |
| iShares GNMA Bond ETF (GNMA) | |||
| TXUG | 25.98 | -0.71 | -2.67% |
| Thornburg International Growth Fund ETF (TXUG) | |||
| TCHP | 49.15 | -1.53 | -3.02% |
| T. Rowe Price Blue Chip Growth ETF (TCHP) | |||
| MKOR | 52.76 | -2.02 | -3.69% |
| Matthews Korea Active ETF (MKOR) | |||